RHEOGENE INC has a total of 21 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and Mexico. Its main competitors in its focus markets biotechnology, organic fine chemistry and pharmaceuticals are BRITISH BIO TECHNOLOGY, SHANGHAI INST PHARMACEUTICAL IND and KATHOLIEKE UNIV LEUVEN K U LEUVEN R&D.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Mexico | 5 | |
#4 | China | 2 | |
#5 | Australia | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry | |
#3 | Pharmaceuticals | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Heterocyclic compounds | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations | |
#6 | Sugars | |
#7 | Unspecified technologies | |
#8 | Fermentation | |
#9 | Acyclic or carbocyclic compounds | |
#10 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Palli Subba Reddy | 12 |
#2 | Kumar Mohan Basavaraju | 6 |
#3 | Tice Colin M | 6 |
#4 | Michelotti Enrique L | 4 |
#5 | Thompson Christine S | 3 |
#6 | Dhadialla Tarlochan S | 3 |
#7 | Cress Dean Ervin | 3 |
#8 | Potter David W | 2 |
#9 | Carlson Glenn Richard | 2 |
#10 | Subba Reddy Palli | 2 |
Publication | Filing date | Title |
---|---|---|
CA2488407A1 | Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex | |
WO02066615A2 | Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system | |
MXPA03007494A | Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system. | |
MXPA03007496A | Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system. |